about
Dehydroepiandrosterone to induce murine models for the study of polycystic ovary syndrome.Report of the international symposium: polycystic ovary syndrome: first Latin-American consensus.Adolescence and polycystic ovary syndrome: current concepts on diagnosis and treatment.The effects of metformin on uterine tissue of hyperandrogenized BALB/c mice.Detrimental effects of hyperandrogenism on uterine functions.Dehydroepiandrosterone and metformin modulate progesterone-induced blocking factor (PIBF), cyclooxygenase 2 (COX2) and cytokines in early pregnant mice.Dehydroepiandrosterone and metformin regulate proliferation of murine T lymphocytes.Effect of hyperandrogenism on ovarian function.Uterine function: from normal to Polycystic Ovarian Syndrome alterations.Prenatal hyperandrogenism and lipid profile during different age stages: an experimental study.Early ovarian follicular development in prepubertal Wistar rats acutely exposed to androgens.Prenatal hyperandrogenism induces alterations that affect liver lipid metabolism.Hyperthyroidism advances luteolysis in the pregnant rat through changes in prostaglandin balance.Lipid Accumulation Product (LAP) and Visceral Adiposity Index (VAI) as Markers of Insulin Resistance and Metabolic Associated Disturbances in Young Argentine Women with Polycystic Ovary Syndrome.Prolactin modulates luteal regression from the coeliac ganglion via the superior ovarian nerve in the late-pregnant rat.Alterations of folliculogenesis in women with polycystic ovary syndromeLink between metformin and the peroxisome proliferator-activated receptor γ pathway in the uterine tissue of hyperandrogenized prepubertal micePeroxisome proliferator-activated receptor gamma and early folliculogenesis during an acute hyperandrogenism conditionRole of macrophage secretions on rat polycystic ovary: its effect on apoptosisTreatment with the synthetic PPARG ligand pioglitazone ameliorates early ovarian alterations induced by dehydroepiandrosterone in prepubertal ratsEpigenetic marks in Polycystic Ovary SyndromePrenatally androgenized female rats develop uterine hyperplasia when adultMetformin improves ovarian insulin signaling alterations caused by fetal programmingPrenatal androgen excess alters the uterine peroxisome proliferator-activated receptor (PPAR) systemFetal programming by androgen excess in rats affects ovarian fuel sensors and steroidogenesisEffects of in utero androgen excess and metformin treatment on hepatic functions
P50
Q37699689-93C8A3BD-4D45-454D-BEE8-D08B8E87F94EQ37747725-7D384971-9FA9-452F-9DD0-89A4CF26AD30Q38569694-C4E6B5B3-0C36-4A86-9AB4-4B5DBCA0D3C3Q45989279-A9ED3A88-B8CF-4DC4-8F0F-301F62CE5581Q46346455-87E7375C-9404-44F7-A31A-D634FACE4878Q46497974-71118475-322A-4FBF-95C1-1872627AC698Q46543846-FA562D15-FF1F-4B1B-BBB5-581651625B30Q46760208-D83FF40B-5928-4E51-A93B-EA9C369B3F93Q47568593-C092CF7A-9F90-4F44-9D71-3FB456A517EFQ50500988-9E0C0F6D-A8F8-4414-9C35-AD3B0F6BB43EQ50891617-0D7E4937-E863-4CB0-B01F-CBCB3185F9FFQ50898377-5702C888-5235-4F90-8C01-64ECC12E28D3Q51016903-1CA1CA54-9F2D-4295-80A3-507A6EA9B27AQ53772055-6FF9C8D4-61C1-457A-965C-A25CAE84CA69Q54192667-02EE9BDC-0E14-479D-A144-35B2FE4C6B1FQ83285950-2B847189-35B0-496B-B4A6-4327CA091AD5Q83554785-96BAE04E-F55A-40C8-BA7F-F587CAD19E2FQ84976182-4F98EE72-AF99-4591-9B0F-F38087AFAB09Q85891080-9C56911D-B2B6-4D8C-A9FC-BDAB0AF65E36Q90218502-89085E94-E7FE-4799-B178-D61D6FDF102BQ90453122-A4F42354-08CD-4313-B62F-93EEE49D6836Q90565169-0726950D-3121-42A6-97FB-9525DEAF71C6Q90943009-E3817B99-7AF9-4B77-AD49-AC66EF6D5520Q91649157-E108843C-CADF-4B25-841F-569820608C8DQ92249576-61025C60-0B78-45E8-854E-2CCED80C84AAQ92421448-DDCB87D6-B128-46C1-8EA1-50E9EC9A3D6C
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
A B Motta
@en
A B Motta
@nl
type
label
A B Motta
@en
A B Motta
@nl
prefLabel
A B Motta
@en
A B Motta
@nl
P31
P496
0000-0002-8478-728X